Page last updated: 2024-09-04

miltirone and Cancer of Liver

miltirone has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwan, YW; Lee, WY; Or, PM; Wan, DC; Wang, Y; Yeung, JH; Zhou, X1

Other Studies

1 other study(ies) available for miltirone and Cancer of Liver

ArticleYear
Miltirone Is a Dual Inhibitor of P-Glycoprotein and Cell Growth in Doxorubicin-Resistant HepG2 Cells.
    Journal of natural products, 2015, Sep-25, Volume: 78, Issue:9

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Caspases; Cell Cycle; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Molecular Structure; Phenanthrenes; Salvia miltiorrhiza

2015